268 related articles for article (PubMed ID: 14745917)
1. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
[TBL] [Abstract][Full Text] [Related]
2. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
Wlodarczyk B; Spiegelstein O; Gelineau-van Waes J; Vorce RL; Lu X; Le CX; Finnell RH
Toxicol Appl Pharmacol; 2001 Dec; 177(3):238-46. PubMed ID: 11749123
[TBL] [Abstract][Full Text] [Related]
3. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
4. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
5. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular abnormalities in Folr1 knockout mice and folate rescue.
Zhu H; Wlodarczyk BJ; Scott M; Yu W; Merriweather M; Gelineau-van Waes J; Schwartz RJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):257-68. PubMed ID: 17286298
[TBL] [Abstract][Full Text] [Related]
7. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development.
Piedrahita JA; Oetama B; Bennett GD; van Waes J; Kamen BA; Richardson J; Lacey SW; Anderson RG; Finnell RH
Nat Genet; 1999 Oct; 23(2):228-32. PubMed ID: 10508523
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
10. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos.
Wlodarczyk BJ; Cabrera RM; Hill DS; Bozinov D; Zhu H; Finnell RH
Neurotoxicology; 2006 Jul; 27(4):547-57. PubMed ID: 16620997
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
12. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
[TBL] [Abstract][Full Text] [Related]
14. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
15. Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation.
Gelineau-van Waes J; Heller S; Bauer LK; Wilberding J; Maddox JR; Aleman F; Rosenquist TH; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):494-507. PubMed ID: 18383508
[TBL] [Abstract][Full Text] [Related]
16. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice.
Craig JC; Bennett GD; Miranda RC; Mackler SA; Finnell RH
Teratology; 2000 Apr; 61(4):305-13. PubMed ID: 10716750
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: folate-responsive neural tube defects and neurocristopathies.
Antony AC; Hansen DK
Teratology; 2000 Jul; 62(1):42-50. PubMed ID: 10861632
[TBL] [Abstract][Full Text] [Related]
19. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Sato M; Shirota M; Nagao T
Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
[TBL] [Abstract][Full Text] [Related]
20. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation.
Spiegelstein O; Mitchell LE; Merriweather MY; Wicker NJ; Zhang Q; Lammer EJ; Finnell RH
Dev Dyn; 2004 Sep; 231(1):221-31. PubMed ID: 15305303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
